› 6bkw

X-ray diffraction
1.5Å resolution

BTK complex with compound 12

Released:
DOI: 10.2210/pdb6bkw/pdb
PDB entry 6bkw coloured by chain, front view.
PDB entry 6bkw coloured by chain, side view.
PDB entry 6bkw coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Water molecules in protein-ligand interfaces. Evaluation of software tools and SAR comparison.
Nittinger E, Gibbons P, Eigenbrot C, Davies DR, Maurer B, Yu CL, Kiefer JR, Kuglstatter A, Murray J, Ortwine DF, Tang Y, Tsui V
J Comput Aided Mol Des 33 307-330 (2019)
PMID: 30756207

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-170299 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Tyrosine-protein kinase BTK Chain: A
Molecule details ›
Chain: A
Length: 287 amino acids
Theoretical weight: 33.88 KDa
Source organism: Homo sapiens
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: Q06187 (Residues: 392-657; Coverage: 40%)
Gene names: AGMX1, ATK, BPK, BTK
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

4 bound ligands:
Ligand SO4 3 x SO4
Ligand DXM 1 x DXM
Ligand FPZ 1 x FPZ
Ligand GOL 2 x GOL
1 modified residue:
Ligand OCS 1 x OCS

Experiments and Validation Details

Entry percentile scores
X-ray source: ESRF BEAMLINE ID23-1
Spacegroup: P61
Unit cell:
a: 108.765Å b: 108.765Å c: 41.863Å
α: 90° β: 90° γ: 120°
R-values:
R R work R free
0.164 0.162 0.19
Expression system: Spodoptera frugiperda

Quick links

Citations

2 review citations

Recent PELE Developments and Applications in Drug Discovery Campaigns.
Puch-Giner et al. (2022)
1 more

2 mentions without citation

A Molecular Dynamics Study of Vasoactive Intestinal Peptide Receptor 1 and the Basis of Its Therapeutic Antagonism.
Latek et al. (2019)
1 more